| scholarly article | Q13442814 |
| P50 | author | Darren J Kelly | Q59540196 |
| Henry Krum | Q82083581 | ||
| Alison Cox | Q101578075 | ||
| Yuan Zhang | Q101978886 | ||
| Jennifer L Wilkinson-Berka | Q37831157 | ||
| Fiona Luise Gill | Q43491213 | ||
| Jennifer Martin | Q44551189 | ||
| P2093 | author name string | Richard E Gilbert | |
| Sally A Mifsud | |||
| P433 | issue | 3 | |
| P304 | page(s) | 694-701 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta | |
| P478 | volume | 65 |
| Q28484321 | A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat |
| Q28583200 | A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II |
| Q40127983 | Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression |
| Q89482746 | Biomarkers for the identification of cardiac fibroblast and myofibroblast cells |
| Q63431935 | Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation |
| Q92728117 | Cardiac fibrosis: potential therapeutic targets |
| Q89920670 | Comparative Study of the Effects of GLP1 Analog and SGLT2 Inhibitor against Diabetic Cardiomyopathy in Type 2 Diabetic Rats: Possible Underlying Mechanisms |
| Q43134093 | Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments. |
| Q27333630 | Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism |
| Q36724656 | Drug discovery for heart failure: a new era or the end of the pipeline? |
| Q42292968 | Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis |
| Q43244408 | Effects of tranilast and pentoxifylline in a mouse model of chronic asthma using house dust mite antigen |
| Q52657397 | Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation. |
| Q33533472 | Expression profiling of mouse embryonic fibroblasts with a deletion in the helicase domain of the Werner Syndrome gene homologue treated with hydrogen peroxide |
| Q50510640 | FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy. |
| Q55000595 | Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase. |
| Q54379957 | Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts. |
| Q36455977 | Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia |
| Q36238505 | Glucocorticoid Insensitivity in Virally Infected Airway Epithelial Cells Is Dependent on Transforming Growth Factor-β Activity. |
| Q39316202 | Implementation studies of ranibizumab for neovascular age-related macular degeneration |
| Q47101405 | Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast |
| Q38631821 | Integrins and integrin-related proteins in cardiac fibrosis |
| Q37728377 | Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes |
| Q42725573 | Long-term prospective pilot study with tranilast for the prevention of stricture progression in patients with Crohn's disease |
| Q27302407 | MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition |
| Q38832985 | MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injury |
| Q90656414 | Natural history, diagnosis and treatment approach to fibrostenosing Crohn's disease |
| Q42061949 | Nox2 contributes to cardiac fibrosis in diabetic cardiomyopathy in a transforming growth factor-β dependent manner |
| Q36921222 | Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations |
| Q35681643 | Pericytes, microvasular dysfunction, and chronic rejection. |
| Q45340524 | Possible antistenotic effect of tranilast in a patient with small bowel tuberculosis to prevent intestinal obstruction due to stenosis progression by antituberculous chemotherapy |
| Q54343681 | Study on the protective effect of shengmai san (see text) on the myocardium in the type 2 diabetic cardiomyopathy model rat. |
| Q83577286 | Study on the protective effect of the Mixture of Shengmai Powder and Danshen Decoction on the myocardium of diabetic cardiomyopathy in the rat model |
| Q43162631 | Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction |
| Q99587532 | Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle? |
| Q37924999 | Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β. |
| Q43915235 | Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy |
| Q89551931 | The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function |
| Q59132980 | The Role of Leukocytes in Diabetic Cardiomyopathy |
| Q84279172 | The Werner syndrome gene product (WRN): a repressor of hypoxia-inducible factor-1 activity |
| Q45994649 | The effect of levocabastine hydrochloride on human Tenon's capsule fibroblasts: inhibition of proliferation, suppression of DNA synthesis and induction of apoptosis. |
| Q35071066 | The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction |
| Q90643368 | Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling |
| Q45919311 | Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD. |
| Q88455884 | Tranilast Blunts the Hypertrophic and Fibrotic Response to Increased Afterload Independent of Cardiomyocyte Transient Receptor Potential Vanilloid 2 Channels |
| Q37539643 | Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice |
| Q46470767 | Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice |
| Q53596970 | Transforming growth factor beta regulates the expression of the M2 muscarinic receptor in atrial myocytes via an effect on RhoA and p190RhoGAP. |
Search more.